找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Evidence-biased Antidepressant Prescription; Overmedicalisation, Michael P. Hengartner Book 2022 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: mountebank
11#
發(fā)表于 2025-3-23 13:29:35 | 只看該作者
12#
發(fā)表于 2025-3-23 17:48:22 | 只看該作者
Flaws in Antidepressant Research,ed by the pharmaceutical industry to serve its commercial interests. The main objective is to outline the conduct and dissemination of antidepressant trials. The author details the multiple methodological limitations of these studies and further explains how study results are selectively reported an
13#
發(fā)表于 2025-3-23 21:47:13 | 只看該作者
Conflicts of Interest in Medicine,issal of harms resulting from medical interventions and the censoring and discrediting of experts questioning the benefit–harm ratio of established healthcare practices. A special emphasis is put on the denial and minimisation of both withdrawal syndromes resulting from physical dependence to antide
14#
發(fā)表于 2025-3-24 01:51:14 | 只看該作者
Solutions for Reform,prescribing of antidepressants in self-limiting, non-severe depression. It also makes suggestion as to how medical research, education, and practice can be freed from corporate bias, thus putting public health and patient safety over the commercial interests of the pharmaceutical industry.
15#
發(fā)表于 2025-3-24 03:21:56 | 只看該作者
16#
發(fā)表于 2025-3-24 09:46:41 | 只看該作者
17#
發(fā)表于 2025-3-24 14:42:02 | 只看該作者
978-3-030-82589-8The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
18#
發(fā)表于 2025-3-24 18:05:06 | 只看該作者
Environmental Business Channels,This chapter provides a short introduction into the themes of this book and the author’s career in psychiatric research. It details how and why the author started to study the efficacy and safety of antidepressants and the corruption of evidence-based medicine.
19#
發(fā)表于 2025-3-24 22:08:09 | 只看該作者
20#
發(fā)表于 2025-3-25 00:18:31 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-26 05:17
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
延川县| 句容市| 贵南县| 永德县| 西和县| 兴安盟| 吉林市| 儋州市| 平顺县| 正镶白旗| 广宗县| 东宁县| 高陵县| 永康市| 榆树市| 乌恰县| 临邑县| 乌恰县| 淮南市| 华亭县| 淄博市| 北川| 滨海县| 咸阳市| 浮梁县| 定结县| 瓦房店市| 景洪市| 大余县| 潼关县| 上杭县| 临高县| 准格尔旗| 利川市| 舟山市| 安化县| 乐至县| 通榆县| 丹东市| 江都市| 汝州市|